VivoSeq
Other

Depressed

0

Pipeline Programs↗

6

Active Trials↗

2

Companies Involved↗

Depressed is an early-stage landscape with 0 programs across 2 companies. The most active players are Sprout Pharmaceuticals, Inc, Pfizer.

Intelligence

Pipeline Metrics

Competitive Density

21/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

74/100

Attrition Rate

17/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

S

Sprout Pharmaceuticals, Inc

0 programs

PreclinicalPfizer logo

Pfizer

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

29

clinical trials

Completed14 · 48%
Recruiting5 · 17%
Unknown status4 · 14%
Terminated4 · 14%
Active, not recruiting1 · 3%
Withdrawn1 · 3%

Clinical Trials

Trial Activity

29 trials

Depressed Mood Improvement Through Nicotine Dosing 3
Recruiting·VVanderbilt University Medical Center·Phase 2·NCT05746273·60 enrolled
Non-invasive BCI and Application Verification for Depressed People
Recruiting·SShanghai Mental Health Center·Phase 4·NCT06417437·400 enrolled
A Study of Ketamine Infusions to Treat Clinically-depressed ICU Patients
Recruiting·MMayo Clinic·Phase 2·NCT05803551·50 enrolled
Neuroactive Steroid to Treat Depressed Mood: A Trial for People With HIV
Recruiting·MMassachusetts General Hospital·Phase 2·NCT05570812·120 enrolled
Reward-specific Changes of the Chemical Messenger Dopamine in the Brain of Healthy and Depressed People
Recruiting·MMedical University of Vienna·Phase 4·NCT06675851·120 enrolled
Depressed Mood Improvement Through Nicotine Dosing-3 (Depressed MIND3) Extension
Active, not recruiting·VVanderbilt University Medical Center·Phase 2·NCT05746546·60 enrolled
Antidepressant Effects on cAMP Specific Phosphodiesterase (PDE4) in Depressed Patients
Completed·National Institute of Mental Health (NIMH)·Phase 1·NCT00369798·100 enrolled
Varenicline in Bipolar Depressed Patients
Completed·—·N/A·NCT00813800·11 enrolled
Study of Mood Effects of Varenicline (Chantix) in Depressed Outpatient Smokers
Completed·—·N/A·NCT00525837·18 enrolled
Efficacy of Mirtazapine in Depressed Cocaine Dependent Subjects
Completed·—·Phase 2·NCT00322309·24 enrolled
Fixed Dose Comparison of Escitalopram to an Active Comparator in Severely Depressed Patients
Completed·FForest Laboratories·Phase 4·NCT00384436·580 enrolled
Study Evaluating Venlafaxine Extended-Release in Depressed and Anxious Patients
Completed·Pfizer logoPfizer·Phase 4·NCT00546923·210 enrolled
Depressed Mood Improvement Through Nicotine Dosing 2
Completed·VVanderbilt University Medical Center·Phase 2·NCT04433767·29 enrolled
Depressed Mood Improvement Through Nicotine Dosing (Depressed MIND Study)
Completed·VVanderbilt University Medical Center·Phase 4·NCT02816138·15 enrolled
Sertraline and Cognitive Therapy in Depressed Alcoholics
Completed·National Institute on Alcohol Abuse and Alcoholism (NIAAA)·Phase 2·NCT00000458·100 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)